A tiered approach to systemic toxicity testing for agricultural chemical safety assessment

Critical Reviews in Toxicology

Volumn 36, Issue 1, 2006, Pages 37-68

  Doe, John E ^a   Boobis, Alan R ^b   Blacker, Ann ^c   Dellarco, Vicki ^d   Doerrer, Nancy G ^e   Franklin, Claire ^f,n   Goodman, Jay I ^g   Kronenberg, Joel M ^h   Lewis, Richard ^a   McConnell, Ernest E ⁱ   Mercier, Thierry ^j   Moretto, Angelo ^k   Nolan, Canice ^l   Padilla, Stephanie ^m   Tilbury, Lorraine ^o,q   Phang, Whang ^d   Solecki, Roland ^p   Van Ravenzwaay, Bennard ^r   Wolf, Douglas C ^m  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c BAYER CROPSCIENCE   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

^f HEALTH CANADA   (Canada)

^g MICHIGAN STATE UNIVERSITY   (United States)

^h MONSANTO COMPANY   (United States)

ⁱ ToxPath Inc   (United States)

^j CEMAGREF   (France)

^k UNIVERSITY OF PADOVA   (Italy)

^l Delegation of the European Commission to the United States   (United States)

^m U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

ⁿ UNIVERSITY OF OTTAWA   (Canada)

^o PFIZER INC   (United States)

^p FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^q DUPONT COMPANY   (United States)

^r BASF SE   (Germany)

more..

Author keywords

Agricultural Chemicals; Health Based Guidance Values; Risk Assessment; SABRE Database; Systemic Toxicity Testing; Tiered Testing

Indexed keywords

2 (4 CHLORO 2 METHYLPHENOXY)ACETIC ACID; 2,4 DICHLOROPHENOXYACETIC ACID; ACETOCHLOR; AGRICULTURAL CHEMICAL; ATRAZINE; BENOMYL; BUTYLATE; CARBARIL; CARBOXIN; DICAMBA; DICOFOL; DIMETHOATE; DIMPYLATE; DIPHENYL ETHER DERIVATIVE; METOLACHLOR; MEVINPHOS; ORGANOPHOSPHATE PESTICIDE; PHOSPHINOTHRICIN; PROPACHLOR; PYRETHROID; TRIALLATE; TRIAZOLE DERIVATIVE; VINCLOZOLIN;

ABSORPTION; ADAPTATION; ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; BIOASSAY; BIOTRANSFORMATION; BODY DISTRIBUTION; CARCINOGENICITY; CROP PROTECTION; DATA BASE; DEVELOPMENTAL STAGE; ENVIRONMENTAL EXPOSURE; EXCRETION; GENETIC TOXICOLOGY; HUMAN; IMMUNOTOXICITY; INFORMATION CENTER; LONG TERM EXPOSURE; MAXIMUM TOLERATED DOSE; METABOLISM; NEUROTOXICITY; NONHUMAN; REFERENCE VALUE; REVIEW; RISK ASSESSMENT; SAFETY; TIME; TOXICITY TESTING; TOXICOKINETICS;

AGROCHEMICALS; DATABASE MANAGEMENT SYSTEMS; ENVIRONMENTAL EXPOSURE; HUMANS; RISK ASSESSMENT; SAFETY MANAGEMENT; TOXICITY TESTS;

ANIMALIA; CANIS FAMILIARIS;

EID: 33644865820     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440500534370     Document Type: Review

References (56)

1. Barton, H.A., Pastoor, T.P., Baetcke, K., Chambers, J.E., Diliberto, J., Doerrer, N.G., Driver, J.H., Hastings, C.E., Iyengar, S., Krieger, R., Stahl, B., and Timchalk, C. (2006). The acquisition and application of absorption, distribution, metabolism, and excretion (ADME) data in agricultural chemical safety assessments. Crit. Rev. Toxicol. 36:9-35.
2. Basketter, D.A., Bremmer, J.N., Buckley, P., Kammuller, M.E., Kawabata, T., Kimber, I., Loveless, S.E., Magda, S., Stringer, D.A., and Vohr, H.-W. (1995). Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology. Food Chem. Toxicol. 33:239-243.
3. Battershill, J.M., and Fielder, R.J. (1998). Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice. Hum. Exp. Toxicol. 17:193-205.
4. Carmichael, N.G., Barton, H.A., Boobis, A.R., Cooper, R.L., Dellarco, V.L., Doerrer, N.G., Fenner-Crisp, P.A., Doe, J.E., Lamb, J.C., and Pastoor, T.P. (2006). Agricultural chemical safety assessment: A multi-sector approach to the modernization of human safety requirements. Crit. Rev. Toxicol. 36:1-7.
5. Cohen, S.M. (2001). Alternative models for carcinogenicity testing: Weight of evidence evaluations across models. Toxicol. Pathol. 29(Suppl.):183-190.
6. Cohen, S.M. (2004). Human carcinogenic risk evaluation: An alternative approach to the two-year rodent bioassay. Toxicol. Sci. 80:225-229.
7. Cohen, S.M., Robinson, D., and MacDonald, J. (2001). Alternative models for carcinogenicity testing. Toxicol. Sci. 64:14-19.
8. Cooper, R.L., Lamb, J.C., Barlow, S.M., Bentley, K., Brady, A.M., Doerrer, N.G., Eisenbrandt, D.L., Fenner-Crisp, P.A., Hines, R.N., Irvine, L., Kimmel, C.A., Koeter, H., Li, A.A., Makris, S.L., Sheets, L., Speijers, G.J.A., and Whitby, K. (2006). A tiered approach to life stages testing for agricultural chemical safety assessment. Crit. Rev. Toxicol. 36:69-98.
9. Counts, J.L., and Goodman, J.I. (1995). Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: Dose influences mechanism. Regul. Toxicol. Pharmacol. 21:418-421.
10. Dourson, M.L., Andersen, M.E., Erdreich, L.S., and MacGregor, J.A. (2001). Using human data to protect the public's health. Regul. Toxicol. Pharmacol. 33:234-256.
11. European Crop Protection Association. (1999). Relationship between no effect levels and low effect levels in rat 28 day and 90 day studies. Unpublished report.
12. Gaylor, D.W. (2005). Are tumor incidence rates telling us what we need to know about carcinogens? Regul. Toxicol. Pharmacol. 41:128-133.
13. Goodman, J.I. (2001). A perspective on current and future uses of alternative models for carcinogenicity testing. Toxicol. Pathol. 29(Suppl.):173-176.
14. Holsapple, M.P. (1995). The plaque-forming cell (PFC) response in immunotoxicology: An approach to monitoring the primary effector function of B-lymphocytes. In: Methods in Immunotoxicology, Vol. 1, G.R. Burleson, J.H. Dean, and A.E. Munson, eds., pp. 71-108, Wiley-Liss, New York.
15. Huff, J.E., Bucher, J.R., Schwetz, B.A., and Barrett, J.C. (1994). Optimum exposure levels for chemical carcinogenesis experiments: Concepts, principles, guidelines, and experience. Toxicologist, SOT Abstract 475.
16. International Programme on Chemical Safety. (2001). Guidance document for the use of data in development of chemical-specific adjustment factors (CSAFs) for interspecies differences and human variability in dose/concentration- response assessment. World Health Organization (WHO), Geneva, Switzerland. http://www.who.int/ipcs/publications/methods/harmonization/en/ csafs_guidance_doc.pdf.
17. Luster, M.I., Munson, A.E., Thomas, P.T., Holsapple, M.P., Fenters, J.D., White, K.L., Jr., Lauer, L.D., Germolec, D.R., Rosenthal, G.J., and Dean, J.H. (1988). Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10:2-19.
18. Luster, M.I., Pait, D.G., Portier, C., Rosenthal, G.J., Germolec, D.R., Comment, C.E., Munson, A.E., White, K., and Pollock, P. (1992a). Qualitative and quantitative experimental models to aid in risk assessment for immunotoxicology. Toxicol. Lett. 64/65:71-78.
19. Luster, M.I., Portier, C., Pait, D.G., White, K.L., Jr., Gennings, C., Munson, A.E., and Rosenthal, G.J. (1992b). Risk assessment in immunotoxicology I: Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200-210.
20. Luster, M.I., Portier, C., Pait, D.G., Rosenthal, G.J., Germolec, D.R., Corsini, E., Blaylock, B.L., Pollock, P., Kouchi, Y., Craig, W., White, D.L., Munson, A.E., and Comment, C.E. (1993). Risk assessment in immunotoxicology II: Relationships between immune and host resistance tests. Fundam. Appl. Toxicol. 21:71-82.
21. McClain, R.M. (1994). Mechanistic considerations in the regulation and classification of chemical carcinogens. In: Nutritional Toxicology, F.N. Kotsonis, M. Mackey, and J. Hjelle, eds., pp. 273-304. Raven Press, New York.
22. McConnell, E. (1989). The maximum tolerated dose: The debate. J. Am. Coll. Toxicol. 8:1115-1120.
23. McConnell, E. (1995). Historical review of the rodent bioassay and future directions. Regul. Toxicol. Pharmacol. 21:38-43.
24. Mead, R. (1988). The Design of Experiments. Cambridge University Press, Cambridge, UK.
25. Monro, A. (1993). How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans? Adverse Drug React. Toxicol. Rev. 12:5-34.
26. Moser, V.C., and MacPhail, R.C. (1990). Comparative sensitivity of neurobehavioural tests for chemical screening. Neurotoxicology 11:335-344.
27. National Research Council. (1993). Use of the maximum tolerated dose in animal bioassays for carcinogenicity. In: Issues in Risk Assessment, B. Goldstein et al., eds., pp. 15-83, National Academies Press, Washington, DC.
28. National Research Council. (2004). Committee on the Use of Third Party Toxicity Research with Human Research Participants, National Research Council of the National Academies. National Academies Press, Washington, DC.
29. National Toxicology Program. (1984). Report of the NTP Ad Hoc Panel on Chemical Carcinogenesis Testing and Evaluation. National Institute of Environmental Health Sciences, Research Triangle Park, NC.
30. National Toxicology Program. (1992). Final report of the advisory review by the NTP Board of Scientific Councilors. Fed. Reg. 57:31721-31730.
31. Organisation for Economic Cooperation and Development. (1981). Health effects test guideline 453. Combined chronic toxicity/carcinogenicity studies. Environment Directorate, Paris, France.
32. Organisation for Economic Cooperation and Development. (1995). Health effects test guideline 407. Repeated dose 28-day oral toxicity study in rodents. Environment Directorate, Paris, France.
33. Organisation for Economic Cooperation and Development. (1998). Health effects test guideline 409. Repeated dose 90-day oral toxicity study in non-rodents. Environment Directorate, Paris, France.
34. Organisation for Economic Cooperation and Development. (2000). Protocol for investigating the efficacy of the Enhanced 407 Test Guideline (phase 2). Rationale for the investigation, and description of the protocol. Environment Directorate, Paris, France.
35. Organisation for Economic Cooperation and Development. (2001). Health effects test guideline 416. Two-generation reproduction toxicity study. Environment Directorate, Paris, France.
36. Popp, J.A. (2001). Criteria for the evaluation of studies in transgenic models. Toxicol. Pathol. 29(Suppl.):20-23.
37. Pritchard, J.B., French, J.E., Davis, B.J., and Haseman, J.K. (2003). Transgenic mouse models: Their role in carcinogen identification. Environ. Health Perspect. 111:444-454.
38. Robinson, D.E., and MacDonald, J.S. (2001). Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. Toxicol. Pathol. 29(Suppl.):13-19.
39. Rozman, K.K., and Doull, J. (2000). Dose and time as a variable of toxicity. Toxicology 144:169-178.
40. Solecki, R. (2001). Pesticide residues in food - 2000. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Core Assessment Group. Annex 5: Proposed test guidelines for studies with single oral doses (for use in establishing acute reference doses for chemical residues in food and drinking water). FAO Plant Production and Protection Paper 163. FAO, Rome, Italy. http://www.fao.org/ag/agp/agpp/ pesticid/jmpr/Download/2000_rep/cont.pdf
41. Sontag, J.M., Page, N.P., and Safiotti, U. (1976). Guidelines for carcinogen bioassay in small rodents. DHHS Publication (NIH) 76-801. National Cancer Institute, Bethesda, MD.
42. Spielmann, H., and Gerbracht, U. (2001). The use of dogs as second species in regulatory testing of pesticides. Part II: Subacute, subchronic and chronic studies in the dog. Arch. Toxicol. 75:1-21.
43. Storer, R.D., French, J.E, Haseman, J., Hajian, G., LeGrand, E.K., Long, G.G., Mixson, L.A., Ochoa, R., Sagartz, J.E., and Soper, K.A. (2001). P53 +/- hemizygous knockout mouse: overview of available data. Toxicol. Pathol. 29(Suppl.):30-50.
44. U.S. Environmental Protection Agency. (1998a). Health Effects Test Guideline OPPTS 870.3100. 90-Day oral toxicity in rodents. EPA 712-C-98-199. Office of Prevention, Pesticides and Toxic Substances, Washington, DC.
45. U.S. Environmental Protection Agency. (1998b). Health Effects Test Guideline OPPTS 870.3150. 90-Day oral toxicity in nonrodents. EPA 712-C-98-200. Office of Prevention, Pesticides and Toxic Substances, Washington, DC.
46. U.S. Environmental Protection Agency. (1998c). Health Effects Test Guideline OPPTS 870.3800. Reproduction and fertility effects. EPA 712-C-98-208. Office of Prevention, Pesticides and Toxic Substances, Washington, DC.
47. U.S. Environmental Protection Agency. (1998d). Health Effects Test Guideline OPPTS 870.4300. Combined chronic toxicity/carcinogenicity. EPA 712-C-98-212. Office of Prevention, Pesticides and Toxic Substances, Washington, DC.
48. U.S. Environmental Protection Agency. (2000). Health Effects Test Guideline OPPTS 870.3050. Repeated dose 28-day oral toxicity study in rodents. EPA 712-C-00-366. Office of Prevention, Pesticides and Toxic Substances, Washington, DC.
49. U.S. Environmental Protection Agency. (2003a). Draft final guidelines for carcinogen risk assessment. Fed. Reg. 68:10012.
50. U.S. Environmental Protection Agency. (2003b). Rodent carcinogenesis studies: dose selection and evaluation. Interim Guidance Document No. G2003.02. Office of Pesticide Programs, Health Effects Division, Washington, DC.
51. U.S. Environmental Protection Agency. (2005). Human Testing; Proposed plan and description of review process. Fed. Reg. 70:6661.
52. Usui, T., Griffiths, S.A., and Lumley, C.E. (1996). Industry viewpoint: The utility of the mouse for the assessment of the carcinogenic potential of pharmaceuticals. In: Proceedings, Third International Conference on Harmonisation, Yokohama, 1995, F. D'Arcy and D.W.G. Harron, eds., pp. 279-284. Greystone Books, Antrim, N. Ireland.
53. Usui, T., Mutai, M., Hisada, S., Takoaka, M., Soper, K.A., McCullough, B., and Alden, C. (2001). CB6F1-rasH2 mouse: Overview of available data. Toxicol Pathol. 29(Suppl.):90-108.
54. Van Oosterhout, J.P., Van der Laan, J.W., De Waal, E.J., Olejniczak, K., Hilgenfeld, M., Schmidt, V., and Bass, R. (1997). The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe. Regul Toxicol. Pharmacol. 25:6-17.
55. Ware, G.W. (2000). The Pesticide Book, 5th ed., Thomson, Fresno, CA.
56. Yamamoto, S., Urano, K., Koizumi, H., Wakana, S., Hioki, K., Mitsumori, K., Kurokawa, Y., Hayashi, Y., and Nomura, T. (1998). Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ. Health Perspect. 106(Suppl. 1):57-69.